After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations.
In 2023, the company split off its consumer health care business into a new publicly traded company, Kenvue Inc. (NYSE: KVUE). In addition, Johnson & Johnson is building a $2 billion ...
Johnson & Johnson (NYSE:JNJ) enters bearish pattern, death cross, but strong dividends & strategic moves in dermatology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback